Furthermore, GSDME mRNA levels also varied significantly between different clinical stages of BLCA, KIRC, and READ (Figure 3F), but were consistently higher in the more advanced stages of KIRC and READ. This evidence concerns the gene GSDME and bladder transitional cell carcinoma.